Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...

The reported valuation aligns with where Manus had been headed before Meta intervened. The company had been raising new funds ...